• Publications
  • Influence
Hepatitis E Virus Antibodies in Blood Donors, France
Using a validated sensitive assay, we found hepatitis E virus (HEV) IgG in 52.5% of voluntary blood donors in southwestern France. This finding suggests HEV is highly endemic to this region. The highExpand
  • 304
  • 36
  • PDF
Hepatitis E virus and chronic hepatitis in organ-transplant recipients.
Hepatitis E virus (HEV) is considered an agent responsible for acute hepatitis that does not progress to chronic hepatitis. We identified 14 cases of acute HEV infection in three patients receivingExpand
  • 980
  • 32
  • PDF
Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants.
BACKGROUND & AIMS Hepatitis E virus (HEV) infection can cause chronic hepatitis in recipients of solid organ transplants. However, the factors that contribute to chronic infection and the outcomes ofExpand
  • 445
  • 21
Hepatitis E Virus Strains in Rabbits and Evidence of a Closely Related Strain in Humans, France
The host range of HEV in Europe is expanding, and zoonotic transmission of HEV from rabbits is possible.
  • 177
  • 21
  • PDF
Hepatitis E Virus Infection
SUMMARY Hepatitis E virus (HEV) infection is a worldwide disease. An improved understanding of the natural history of HEV infection has been achieved within the last decade. Several reservoirs andExpand
  • 227
  • 18
Ribavirin for chronic hepatitis E virus infection in transplant recipients.
BACKGROUND There is no established therapy for hepatitis E virus (HEV) infection. The aim of this retrospective, multicenter case series was to assess the effects of ribavirin as monotherapy forExpand
  • 321
  • 14
  • PDF
Hepatitis E
Hepatitis E virus (HEV) was discovered during the Soviet occupation of Afghanistan in the 1980s, after an outbreak of unexplained hepatitis at a military camp. A pooled faecal extract from affectedExpand
  • 56
  • 10
Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic Syndrome
Atypical hemolytic and uremic syndrome (aHUS) is a severe disease strongly associated with genetic abnormalities in the complement alternative pathway. In renal posttransplantation, few data areExpand
  • 177
  • 9
Risk Factors of Pneumocystis Pneumonia in Solid Organ Recipients in the Era of the Common Use of Posttransplantation Prophylaxis
Pneumocystis pneumonia (PCP) in solid organ transplant (SOT) recipients becomes rare in the immediate posttransplantation period thanks to generalized prophylaxis. We aimed to identify the predictiveExpand
  • 59
  • 9
Efficacy and Safety of Sofosbuvir‐Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation
There is no approved therapy for hepatitis C virus (HCV) infection after kidney transplantation, and no data regarding the use of new‐generation direct antiviral agents (DAAs) have been published soExpand
  • 157
  • 8